According to a newly published market research report by 24LifeSciences, the global chronic ocular surface pain market was valued at USD 2.1 billion in 2024 and is projected to reach USD 3.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025–2032. Chronic Ocular Surface Pain (COSP) is a complex and debilitating condition...